Veristat and CITELINE hosted a webinar on the topic: Single-Arm Studies for Use as a Registrational Study in Oncology
Webinar | Impact of New Medical Device EU Regulation (MDR) on the Development of Drug-Device Combination Products
May 10, 2023
Veristat and TOPRA hosted a webinar on the topic: Impact of New EU Regulations on the Development of Medical Devices and Drug Combination Products
Bio Asia 2023
May 2, 2023
Meet Veristat at the Bio Asia Taiwan 2023 taking place on the 26-30 July 2023
MedTech Forum 2023
April 28, 2023
Meet Veristat at the MedTech Forum 2023 taking place on the 30th May – 1st June 2023
OCT Conference 2023
April 28, 2023
Meet Veristat at the Outsourcing in Clinical Trials Europe 2023 taking place on the 3th - 4th May 2023
Marcus Evans Evolution Summit May 2023
April 20, 2023
Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit
ASGCT Annual Meeting 2023
April 18, 2023
Veristat’s John Balser, PhD., will be presenting in the scientific symposium
DIA Global Annual Meeting 2023
April 3, 2023
Attend our Innovation Theater Presentation on Decentralized Clinical Trials
Swiss Biotech Day 2023
March 30, 2023
Veristat and SFL, a Veristat company, will attend the Swiss Biotech Day 2023
Veristat and TOPRA hosted a new updated content webinar on the topic: Future Trends on European Regulations on Medicines
What You Will Learn
The European Commission announced on 25 November 2020 the adoption of the new Pharmaceutical Strategy for Europe. It is an approach intended to ensure strong, fair competitivity and green industry, fostering patient access to innovative and affordable medicines. It will ensure an autonomous and robust supply chain and a stronger EU voice at the global level by promoting a high level of quality, efficacy and safety standards.